Pharmaceutical Executive - Pharmaceutical news and analysis. Pharma management, sales, marketing & finance

ADVERTISEMENT

Previous Story Play / Pause Next Story
New & Noteworthy
Emerging Pharma Leaders 2014
This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise—all binded by an underlying commitment to the patient.
A Window on the Industry: The Emerging Pharma Leaders 2014
Pharm Exec's 2014 roster of emerging pharma leaders serves as a window on work in an industry that relies on human capital as the coinage of success, writes William Looney.
Brown University's Masters in Healthcare Leadership: A Mission to Transform
Mid-career students on Brown University's new program are challenged to remove the organizational silos that slow innovations in the delivery and financing of healthcare.

Latest Pharm Exec Videos

Events
Medicaid and Government Pricing Congress
June 3, 2015 - June 5, 2015
Lake Buena Vista, FL USA

PAAS 2015 – Patient Adherence and Access Summit
June 16, 2015 - June 17, 2015
Philadelphia, PA USA

13th Annual Product Complaints Congress for Life Sciences
June 23, 2015 - June 25, 2015
Washington, DC USA

Contracts, Chargebacks and Rebates Congress
June 24, 2015 - June 25, 2015
Philadelphia, PA USA

UK: Controversial Cancer Fund Boosted  But What s the Long-Term Plan?
Europe: More Direct-Acting Antivirals, More Controversy
From the Generic to the Supergeneric Era
Positive Results for Ebola Vaccine
China Closes In On US As Biggest Healthcare Market
Ebola Debates Turn Everyone into an Expert
Pricing Tom NortonManaging High Priced, US Biotech Rxs in Canada
Technology Peter HoustonApple or Big Pharma: Who Will Lead in the Wearable Healthcare Technology Space?
Deals William LooneyPharm Exec's Dealmakers Outlook
Social Media Regulation PharmExecPharm Exec Global Digest FDA & Social Media Special
 More
Survey
What is your area of key concern for the industry's future?
Increasing regulation
Price controls
Lack of new products in pipeline
Patent expirations
Retaining and developing future leaders
Increasing regulation
25%
Price controls
25%
Lack of new products in pipeline
33%
Patent expirations
8%
Retaining and developing future leaders
8%
View Results
PHARM EXEC GLOBAL DIGEST
Pharmaceutical Executive Digest EuropeTo read the latest issue of Pharm Exec Global Digest
Click here. Click here to receive the Digest into your inbox every month.
Click here